ELEVANCE HEALTH INC (1ANTM.MI) Fundamental Analysis & Valuation

BIT:1ANTM • US0367521038

Current stock price

315.5 EUR
+11.3 (+3.71%)
Last:

This 1ANTM.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. 1ANTM.MI Profitability Analysis

1.1 Basic Checks

  • 1ANTM had positive earnings in the past year.
  • In the past year 1ANTM had a positive cash flow from operations.
  • Each year in the past 5 years 1ANTM has been profitable.
  • 1ANTM had a positive operating cash flow in each of the past 5 years.
1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCF1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.51%, 1ANTM is in the better half of the industry, outperforming 78.13% of the companies in the same industry.
  • The Return On Equity of 1ANTM (12.59%) is better than 68.75% of its industry peers.
  • The Return On Invested Capital of 1ANTM (5.60%) is comparable to the rest of the industry.
  • 1ANTM had an Average Return On Invested Capital over the past 3 years of 6.90%. This is in line with the industry average of 6.06%.
Industry RankSector Rank
ROA 4.51%
ROE 12.59%
ROIC 5.6%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1ANTM.MI Yearly ROA, ROE, ROIC1ANTM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • With a decent Profit Margin value of 2.84%, 1ANTM is doing good in the industry, outperforming 65.63% of the companies in the same industry.
  • 1ANTM's Profit Margin has declined in the last couple of years.
  • The Operating Margin of 1ANTM (4.35%) is comparable to the rest of the industry.
  • 1ANTM's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.35%
PM (TTM) 2.84%
GM N/A
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
1ANTM.MI Yearly Profit, Operating, Gross Margins1ANTM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. 1ANTM.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1ANTM is destroying value.
  • Compared to 1 year ago, 1ANTM has less shares outstanding
  • 1ANTM has less shares outstanding than it did 5 years ago.
  • 1ANTM has a worse debt/assets ratio than last year.
1ANTM.MI Yearly Shares Outstanding1ANTM.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
1ANTM.MI Yearly Total Debt VS Total Assets1ANTM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • 1ANTM has a debt to FCF ratio of 8.63. This is a slightly negative value and a sign of low solvency as 1ANTM would need 8.63 years to pay back of all of its debts.
  • 1ANTM's Debt to FCF ratio of 8.63 is in line compared to the rest of the industry. 1ANTM outperforms 59.38% of its industry peers.
  • 1ANTM has a Debt/Equity ratio of 0.71. This is a neutral value indicating 1ANTM is somewhat dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.71, 1ANTM belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 8.63
Altman-Z N/A
ROIC/WACC0.66
WACC8.46%
1ANTM.MI Yearly LT Debt VS Equity VS FCF1ANTM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
1ANTM.MI Yearly Current Assets VS Current Liabilites1ANTM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 1ANTM.MI Growth Analysis

3.1 Past

  • 1ANTM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.71%.
  • Measured over the past years, 1ANTM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.17% on average per year.
  • Looking at the last year, 1ANTM shows a quite strong growth in Revenue. The Revenue has grown by 11.96% in the last year.
  • Measured over the past years, 1ANTM shows a quite strong growth in Revenue. The Revenue has been growing by 11.14% on average per year.
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%12%

3.2 Future

  • 1ANTM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.64% yearly.
  • The Revenue is expected to grow by 4.62% on average over the next years.
EPS Next Y-8.14%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
EPS Next 5Y7.64%
Revenue Next Year13.09%
Revenue Next 2Y8.09%
Revenue Next 3Y6.88%
Revenue Next 5Y4.62%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1ANTM.MI Yearly Revenue VS Estimates1ANTM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50B 100B 150B 200B
1ANTM.MI Yearly EPS VS Estimates1ANTM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

More info and screens

Find the best growth stocksShow best growing peers

4

4. 1ANTM.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1ANTM is valuated reasonably with a Price/Earnings ratio of 11.95.
  • Based on the Price/Earnings ratio, 1ANTM is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
  • 1ANTM is valuated cheaply when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 13.42, 1ANTM is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ANTM indicates a somewhat cheap valuation: 1ANTM is cheaper than 65.63% of the companies listed in the same industry.
  • 1ANTM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 11.95
Fwd PE 13.42
1ANTM.MI Price Earnings VS Forward Price Earnings1ANTM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 1ANTM's Enterprise Value to EBITDA ratio is in line with the industry average.
  • 1ANTM's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. 1ANTM is more expensive than 65.63% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.89
EV/EBITDA 10.45
1ANTM.MI Per share data1ANTM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.07
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. 1ANTM.MI Dividend Analysis

5.1 Amount

  • 1ANTM has a Yearly Dividend Yield of 1.79%.
  • 1ANTM's Dividend Yield is a higher than the industry average which is at 1.63.
  • Compared to an average S&P500 Dividend Yield of 1.89, 1ANTM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.79%

5.2 History

  • The dividend of 1ANTM is nicely growing with an annual growth rate of 15.34%!
Dividend Growth(5Y)15.34%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 27.56% of the earnings are spent on dividend by 1ANTM. This is a low number and sustainable payout ratio.
  • The dividend of 1ANTM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP27.56%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
1ANTM.MI Yearly Income VS Free CF VS Dividend1ANTM.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
1ANTM.MI Dividend Payout.1ANTM.MI Dividend Payout, showing the Payout Ratio.1ANTM.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1ANTM.MI Fundamentals: All Metrics, Ratios and Statistics

ELEVANCE HEALTH INC

BIT:1ANTM (1/7/2026, 7:00:00 PM)

315.5

+11.3 (+3.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-21
Earnings (Next)01-28
Inst Owners91.68%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap70.12B
Revenue(TTM)194.82B
Net Income(TTM)5.53B
Analysts73.57
Price Target335.28 (6.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.79%
Yearly Dividend5.64
Dividend Growth(5Y)15.34%
DP27.56%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.38%
Min EPS beat(2)-2.26%
Max EPS beat(2)21.02%
EPS beat(4)3
Avg EPS beat(4)5.76%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)5
Avg EPS beat(8)0.95%
EPS beat(12)8
Avg EPS beat(12)1.31%
EPS beat(16)11
Avg EPS beat(16)1.68%
Revenue beat(2)2
Avg Revenue beat(2)0.95%
Min Revenue beat(2)0.45%
Max Revenue beat(2)1.45%
Revenue beat(4)3
Avg Revenue beat(4)1.37%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)5
Avg Revenue beat(8)0.79%
Revenue beat(12)7
Avg Revenue beat(12)1%
Revenue beat(16)10
Avg Revenue beat(16)0.86%
PT rev (1m)5.44%
PT rev (3m)5.44%
EPS NQ rev (1m)-24.94%
EPS NQ rev (3m)-24.94%
EPS NY rev (1m)0.31%
EPS NY rev (3m)0.31%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0.68%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE 11.95
Fwd PE 13.42
P/S 0.42
P/FCF 21.89
P/OCF 16.74
P/B 1.85
P/tB 19.51
EV/EBITDA 10.45
EPS(TTM)26.41
EY8.37%
EPS(NY)23.51
Fwd EY7.45%
FCF(TTM)14.41
FCFY4.57%
OCF(TTM)18.85
OCFY5.97%
SpS754.6
BVpS170.24
TBVpS16.17
PEG (NY)N/A
PEG (5Y)1.07
Graham Number318.06
Profitability
Industry RankSector Rank
ROA 4.51%
ROE 12.59%
ROCE 7.32%
ROIC 5.6%
ROICexc 6.06%
ROICexgc 10.93%
OM 4.35%
PM (TTM) 2.84%
GM N/A
FCFM 1.91%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexgc growth 3Y-5.49%
ROICexgc growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 8.63
Debt/EBITDA 3.13
Cap/Depr 74.45%
Cap/Sales 0.59%
Interest Coverage 250
Cash Conversion 48.59%
Profit Quality 67.25%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC8.46%
ROIC/WACC0.66
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
EPS Next Y-8.14%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
EPS Next 5Y7.64%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%12%
Revenue Next Year13.09%
Revenue Next 2Y8.09%
Revenue Next 3Y6.88%
Revenue Next 5Y4.62%
EBIT growth 1Y-10.69%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-2.04%
EBIT Next 3Y0.56%
EBIT Next 5Y8.31%
FCF growth 1Y-54.88%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-48.85%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%

ELEVANCE HEALTH INC / 1ANTM.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ELEVANCE HEALTH INC (1ANTM.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1ANTM.MI.


What is the valuation status of ELEVANCE HEALTH INC (1ANTM.MI) stock?

ChartMill assigns a valuation rating of 5 / 10 to ELEVANCE HEALTH INC (1ANTM.MI). This can be considered as Fairly Valued.


How profitable is ELEVANCE HEALTH INC (1ANTM.MI) stock?

ELEVANCE HEALTH INC (1ANTM.MI) has a profitability rating of 4 / 10.


What is the financial health of ELEVANCE HEALTH INC (1ANTM.MI) stock?

The financial health rating of ELEVANCE HEALTH INC (1ANTM.MI) is 3 / 10.


What is the expected EPS growth for ELEVANCE HEALTH INC (1ANTM.MI) stock?

The Earnings per Share (EPS) of ELEVANCE HEALTH INC (1ANTM.MI) is expected to decline by -8.14% in the next year.